- Home
- MediaOutReach
- Sanofi sets Singapore Book of Records with the ‘Largest Mural of Magnetic Hands' - a Public Pledge against Respiratory Syncytial Virus (RSV) in Nationwide Awareness Campaign
Sanofi sets Singapore Book of Records with the ‘Largest Mural of Magnetic Hands' - a Public Pledge against Respiratory Syncytial Virus (RSV) in Nationwide Awareness Campaign
Senin, 13 Oktober 2025 | 21:38
(L to R: Ruby Dizon, Vaccines Medical Head, Sanofi SEA & India, Dr Adrian Tan, Founder & Medical Director of Babysteps Medical and Babysteps & Beyond Family & Child Clinic, Mr Ong Eng Huat, Founder & President of Singapore Book of Record, Zainab Sadat, Vaccines General Manager, Sanofi SEA & India and Eric Mansion, Pharma General Manager & MCO Lead, Sanofi SEA & India)
SINGAPORE -
Media OutReach Newswire - 13 October 2025 -
Sanofi
has made history with a nationwide public health activation by
clinching a spot in the Singapore Book of Records with the 'Largest
Mural of Magnetic Hands', a public pledge against Respiratory Syncytial
Virus (RSV) in its
Together Against RSV campaign. The striking mural featured a
total of over 1,000 hand pledges, each representing a parent, caregiver,
or supporter who committed to raising awareness of Respiratory
Syncytial Virus (RSV) – a common yet potentially serious virus – and
protecting all infants from its risks.
Over the three-day event at Serangoon NEX, families, healthcare
partners, and community members came together to symbolically place
hand-shaped magnets on a panelled mural, with each hand carrying a
personal pledge of commitment to learning about and fighting against
RSV.
Zainab Sadat, Head of Vaccines, Sanofi Southeast Asia & India
"This record is more than just numbers; it is a symbol of unity and a
testament to the collective power of Singaporean families, healthcare
professionals, and communities coming together for a cause that truly
matters. Through our 'Together Against RSV' campaign, we hope to spark
ongoing conversations about RSV and empower parents with knowledge and
preventive measures, including immunisation options, to protect their
little ones. Together, we are building a future where every baby can
breathe a little easier, and every family can rest a little more
peacefully."
The mural, measuring 2 meters tall by 5.1 meters wide, now serves as a
striking visual reminder of the nation's shared commitment to combating
RSV. The event also complemented wider awareness initiatives, including
collaborations with hospitals, parent communities, and an educational
microsite (TogetherAgainstRSV.sg) in collaboration with the Singapore
Paediatric Society, as part of Sanofi's mission to empower parents with
trusted information and preventive solutions.
Around the world, about two in three infants contract RSV before their first birthday
1,
making it the most common cause of lower respiratory tract infections,
including bronchiolitis and pneumonia, in young children
2. In
Singapore, RSV is also a leading cause of infant hospitalisations, with
the majority of cases occurring in otherwise healthy, full-term babies.
Each year, an estimated 1,804 children under 29 months are hospitalised
due to RSV-related illness
3-7.
BERITA LAINNYA
BERIKAN KOMENTAR